David Sans
Geen lopende functies
Vermogen: 2 930 $ op 30-04-2024
Profiel
David Sans worked as the Head of Business Development at ImClone LLC and as the Chief Corporate Development at Calidi Biotherapeutics, Inc. He holds a doctorate degree from Ramon Llull University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-09-2023 | 18 314 ( 0.05% ) | 2 930 $ | 30-04-2024 |
Eerdere bekende functies van David Sans
| Bedrijven | Functie | Einde |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
| CALIDI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van David Sans
| Ramon Llull University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
